Venlafaxine Hydrochloride
Product Images NDC 53002-2365

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 53002-2365). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530022365)

The image shows a Venlafaxine Hydrochloride 75 mg ER-Capsules label from RPK Pharmaceuticals, Inc. The label instructs to take one capsule daily or as directed and displays product NDC 53002-2365-9. It includes capsule and drug identification details, lot number, expiration date, dispense quantity of 90 capsules, and spaces for patient and prescriber information. The label is primarily black and white with QR and barcodes.*

FDA Label Image

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)

A pharmacokinetic chart showing the fold change and 90% confidence interval of venlafaxine exposure (Cmax, AUC, ODV) when co-administered with various interacting drugs including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The chart provides recommendations such as dose adjustments or cautionary use based on observed changes relative to reference values.*

FDA Label Image

Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Venlafaxine Fig2)

A pharmacokinetic fold change chart showing the impact of various interacting drugs on analytes including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The chart plots the PK fold change for Cmax and AUC with 90% confidence intervals, alongside clinical recommendations such as dose adjustment guidance or clinical significance notes.*

FDA Label Image

Figure 3: Pharmacokinetics Of Venlafaxine And Its Metabolite O-desmethylvenlafaxine (odv) In Special Populations. (Venlafaxine Fig3)

A scatter plot chart showing pharmacokinetic (PK) parameter changes for venlafaxine in various special populations, including hepatic and renal impairments, CYP2D6 metabolizer status, age, and gender. The chart displays fold changes and 90% confidence intervals relative to reference values for Cmax and AUC, alongside dosage adjustment recommendations.*

FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical structure diagram of venlafaxine hydrochloride showing its molecular framework with labeled functional groups, including a methoxy-substituted aromatic ring, cyclohexane ring, and dimethylamino group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.